Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
2.550
-0.150 (-5.56%)
At close: Sep 17, 2025, 4:00 PM EDT
2.610
+0.060 (2.35%)
Pre-market: Sep 18, 2025, 9:10 AM EDT
Absci Revenue
Absci had revenue of $593.00K in the quarter ending June 30, 2025, a decrease of -53.31%. This brings the company's revenue in the last twelve months to $4.14M, up 27.32% year-over-year. In the year 2024, Absci had annual revenue of $4.53M, down -20.71%.
Revenue (ttm)
$4.14M
Revenue Growth
+27.32%
P/S Ratio
74.06
Revenue / Employee
$26,357
Employees
157
Market Cap
381.28M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.53M | -1.18M | -20.71% |
| Dec 31, 2023 | 5.72M | -29.00K | -0.50% |
| Dec 31, 2022 | 5.75M | 965.00K | 20.18% |
| Dec 31, 2021 | 4.78M | 2.00K | 0.04% |
| Dec 31, 2020 | 4.78M | 2.72M | 132.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
ABSI News
- 6 days ago - Absci Boosts AI-Powered Drug Discovery With Oracle And AMD Collaboration - Benzinga
- 7 days ago - Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD - GlobeNewsWire
- 9 days ago - Absci Corporation (ABSI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 23 days ago - Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg - GlobeNewsWire
- 4 weeks ago - Absci to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Absci Corporation (ABSI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results - GlobeNewsWire
- 6 weeks ago - Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target - GlobeNewsWire